BioSpace News Archive

NexImmune, Inc. (Nasdaq: NEXI), today announced it plans to report third quarter financial results and provide a corporate update on Friday, November 12, 2021, via press release, prior to the market open.

Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), today reported financial results and provided an update on corporate activities for the quarter ended September 30, 2021.

Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for diseases of the eye, today announced that it will report third quarter 2021 financial results on Monday, November 15, 2021.

Cytokinetics, Incorporated announced two presentations at the American Heart Association Scientific Sessions 2021, taking place online from November 13, 2021 – November 15, 2021, including the presentation of additional results from GALACTIC-HF assessing the effect of omecamtiv mecarbil on stroke in patients with heart failure with reduced ejection fraction, and the presentation of preclinical data relating to a cardiac troponin activator that is a closely related analog to CK-3828136.

SeaSpine Holdings Corporation, a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced the Company will participate in upcoming virtual investor conferences.

Tricida, Inc., a pharmaceutical company focused on the development and commercialization of its investigational drug candidate, veverimer, a non-absorbed, orally-administered polymer designed to slow chronic kidney disease progression in patients with metabolic acidosis and CKD, announced financial results for the three and nine months ended September 30, 2021 and provided an update on key initiatives.

Black Diamond Therapeutics, Inc. today reported financial results for the third quarter ended September 30, 2021 and provided a corporate update.

Keros Therapeutics, Inc. (“Keros”) (Nasdaq: KROS), today announced that it will present results from a preclinical study of a research form of KER-012 (“RKER-012”) at the American Heart Association (“AHA”) 2021 Scientific Sessions,

Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on transforming medicines to transform lives, today provided a corporate update and announced its financial results for the third quarter ended September 30, 2021.

Jasper Therapeutics, Inc. (NASDAQ: JSPR), a biotechnology company focused on hematopoietic cell transplant therapies, today announced that Bill Lis, Executive Chairman, and Chief Executive Officer, will present at the Credit Suisse 30th Annual Virtual Healthcare Conference on Wednesday, November 10, 2021, at 11:40 a.m. Pacific Time.